Skip to Main Content

As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

A study published this week in Cancer Cell investigated how cancer cells can rob mitochondria from T cells, shutting the immune cell down while energizing themselves. It may be yet another way cancer overcomes both the body’s defenses and resists many immunotherapies like CAR-T therapy and immune checkpoint blockade drugs, experts said.

advertisement

“This is a new mechanism of immune evasion. It seems like the cancer cells are draining mitochondria from the T cells,” said Bo Li, a cancer researcher at the University of Pennsylvania and Children’s Hospital of Philadelphia and a senior author on the paper. “It’s really amazing. Some of my colleagues, their reaction was like, ‘I can’t believe this is true.’ I understand that. It’s just like the cancer cell is too smart.”

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.